“showed a trend”

Additionally, pS6RP Ser235/236 showed a trend towards increase (FC = 1.92, p = 0.0971).

Poults fed SBM showed a trend for growing more slowly during wk 2 in comparison to birds in other treatments ( P = 0.0972).

Mean Vimentin Western blot signals in Eribulin-treated TNBC cell lines showed a trend of increased levels ( P = 0.0973).

Definite CRT (compared to definitive RT) showed a trend toward worse outcome in the recurrent/residual group (OR=3.5, p = 0.0975) and in the total group (OR = 3.0, p = 0.0854).

While LVESD showed a trend toward reduction in TNC-KO diabetic mice compared to WT diabetic mice ( p = 0.0975), LVEDD remained unchanged between these groups.

However, 5xFAD mice treated with a combination of SB290157 and methylphenidate showed a trend towards improved DI when compared to 5xFAD with vehicle ( p = 0.0979, Fig. 5 e).

Kaplan-Meier analysis showed a trend for higher 3-year OS (89.1% vs. 67.5%; p = 0.098) and DFS (70.0% vs. 52.6%; p = 0.138) for the patients in the Responders’ group, although the differences failed for significance (Fig. 1 ).

6.6 months, HR = 0.68, 95% CI: 0.49–0.93, P = 0.017), and showed a trend toward longer OS (28.2 months vs. 19.0 months, HR = 0.74, 95% CI: 0.52–1.06, P = 0.098), suggesting a potential therapeutic advantage of molecularly guided treatment in CUP patients.

A meta-analysis where the prior cohort study was excluded, showed a trend towards reduced risk of OC with tubal-ligation in BRCA 1 mutation carriers (odds ratio 0.69, p = 0.098), but not in BRCA 2 mutation carriers (odds ratio 0.73, p = 0.33), likely due to small number [ 42 ].

Patients with higher diversity showed a trend toward lower gut aGVHD (11.1% ± 4.7% [SE] vs 24.4% ± 6.4% [SE]; P = .098), whereas no differences were found between the groups in terms of BSI (23.8% ± 6.6% [SE] vs 20.9% ± 6.2% [SE]; P = .735) and TRM (8.9% ± 4.2% [SE] vs 15.6% ± 6.2% [SE]; P = .473; supplemental Figure 4 ).

In the unadjusted model (Model 1), NSAIDs use showed a trend toward lower odds of AKI before matching (OR 0.85, 95% CI 0.69–1.03; p = 0.098) and was associated with higher odds of prolonged stay (OR 1.23, 95% CI 1.14–1.34; p < 0.001).

These adjusted models showed a trend toward a treatment effect for ADAS-cog (P = 0.098) and indicated significantly less HV loss for tramiprosate 100 mg (P = 0.035) and 150 mg (P = 0.009) compared to placebo.

The 2M-DOX group showed a trend toward decreased myeloperoxidase ( p = 0.098) expression in comparison to the 2M-Control group (Fig. 5 F).

The final model performed similarly to the less expansive model without CMMSE with similar variance (R2=13.4% in both models), with no significant influence conferred by cognitive performance and immune-endocrine profile, while MTA score showed a trend towards increased odds for baseline physical frailty (OR=1.72, 95% C.I 0.90-3.25, p=0.098).

Celastrol administration showed a trend towards decreasing the IL-10 production induced by the whey hydrolysate with a DH of 6% ( p = 0.098).

Furthermore SNORD113.6 showed a small but significant correlation with total leukocytes (B = 0.012, p = 0.026), whereas SNORD113.2 showed a trend towards an inverse correlation with total leukocytes (B = −0.746, p = 0.098).

Baseline values showed a trend to a significant difference between groups in FES-I ( p = 0.098 trend) and no significant difference in GDS ( p = 0.104).

The compulsive factor showed a trend‐level association ( R 2 = 0.82%, p = 0.098, Figure 3a ).

4B ), and the ranked amplitude of abductor hallucis MEPs showed a trend ( b = 0.0011, CI: −0.0002, 0.0024, P = 0.098, marginal R 2 = 0.04).

Coinfected patients with advanced hepatic fibrosis (F2–F4) showed a trend towards reduced α-diversity compared with patients with mild hepatic fibrosis (F0–F1) (p = 0.098–p = 0.078, data not shown).

Furthermore, downregulation of miR-34a in GC samples predicted poorer outcome in overall survival ( P = 0.024) [ 36 ], but for recurrence free survival, decreased miR-34a only showed a trend to correlate with poor prognosis ( P = 0.098, Fig. 6c and Additional file 7 : Table S6).

FOG score changes and FAB scale changes within the RT group showed a trend toward significant negative correlation (Rho = −0.553, p = 0.098).

Presence of tingible body macrophages showed a trend toward negative node status ( p = 0.098), while the presence of adipose tissue, necrotic material and polymorphs did not affect node status ( p > 0.05) ( Table 3 ).

In comparison with MYC control, SU cells with stable expression of HOXA9 showed a trend for more sphere formation ( p = 0.098, t -test, Supplementary Fig.

The resilience score also showed a trend-level insignificant association ( p = 0.098).